Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM-TC.

Doriane Cavalieri Marie-Therese Rubio Alexandrine CorrigerBruno PereiraAurélie Cabrespine Marie Robin Hélène Labussière-Wallet Anne Calleja Edouard Forcade Patrice Chevallier Gaelle GuillermAna BerceanuClaude-Eric BulaboisNatacha MaillardStéphanie NguyenNicole RausHélène M Schoemans Jacques-Olivier Bay Aurélie Ravinet

Published in: European journal of haematology (2022)

Neither the indication of HSCT2 nor the source of stem cell was more advantageous towards overall patient survival. A salvage haploidentical or cord-blood stem cell transplantation is a high-risk procedure, that may be considered for patients achieving a complete remission before receiving the second HSCT.

Keyphrases

stem cell transplantation
cord blood
high dose
stem cells
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
hematopoietic stem cell
low dose
prognostic factors
case report
minimally invasive
systemic lupus erythematosus
rheumatoid arthritis
peripheral blood